A lawsuit filed April 25 against AbbVie alleges the company engaged in a “fraudulent scheme” to hike prices by 470 percent of its most profitable drug, Humira.
A lawsuit filed April 25 against AbbVie alleges the company engaged in a “fraudulent scheme” to hike prices by 470 percent of its most profitable drug, Humira.
Copyright © 2024 | WordPress Theme by MH Themes